Brain FDG-PET Scan and Brain Perfusion SPECT in the Diagnosis of Neuroacanthocytosis Syndromes/Nöroakantositoz Sendromlarinin Tanisinda Beyin FGD-PET Görüntüleme ve Beyin Perfüzyon SPECT

Neuroacanthocytosis syndromes (NA) include autosomal recessive chorea-acanthocytosis and X-linked McLeod syndrome consisting of a choreatic movement disorder, psychiatric manifestations and cognitive decline, and additional multi-system features including myopathy and axonal neuropathy. Fluor 18 -2-...

Full description

Saved in:
Bibliographic Details
Published inMolecular imaging and radionuclide therapy Vol. 24; p. 16
Main Authors Degirmenci, Eylem, Yüksel, Dogangün
Format Journal Article
LanguageEnglish
Published Ankara Galenos Publishing House 01.06.2015
Online AccessGet full text

Cover

More Information
Summary:Neuroacanthocytosis syndromes (NA) include autosomal recessive chorea-acanthocytosis and X-linked McLeod syndrome consisting of a choreatic movement disorder, psychiatric manifestations and cognitive decline, and additional multi-system features including myopathy and axonal neuropathy. Fluor 18 -2-fluoro-2-deoxyglucose (^sup 18^F-FDG-PET) positron emission tomography (PET) and technetium 99m -d, l-hexamethyl-propylene amine oxime (^sup 99m^Tc-HMPAO) brain single photon emission computed tomography (SPECT) have been increasingly used for the detection of neurologic disorders, such as dementia, epilepsy, and movement disorders. In this case report, we report two patients with neuroacanthocytosis syndromes with the imaging features of brain metabolism by PET and brain perfusion by SPECT. Brain PET and brain SPECT findings of patients with neuroacanthocytosis syndromes were also reviewed.
ISSN:2146-1414
2147-1959
DOI:10.4274/mirt.35229